| Literature DB >> 29116211 |
Younhea Jung1, Hae-Young L Park1, Yi Ryeung Park2, Chan Kee Park3.
Abstract
It is generally acknowledged that structural loss can precede functional loss in some patients with early glaucoma. However, conventional standard automated perimetry (SAP) has limitations in the detection of functional loss, especially in the macular area. This study explores visual field loss in the macular areas of patients with preperimetric glaucoma exhibiting structural thinning in the area by examining the correlations between the ganglion cell-inner plexiform layer (GCIPL) and the results of matrix frequency-doubling technology (FDT) 10-2 tests. The structure-function relationships between the GCIPL thicknesses and the mean sensitivities (MSs) of the corresponding areas based on conventional SAP 24-2, FDT 10-2, and FDT 24-2 were examined in 62 patients. The highest correlation was found for FDT 10-2 (r = 0.544, P < 0.001) followed by FDT 24-2 (r = 0.433, P = 0.002) and SAP (r = 0.346, P = 0.007). The correlation coefficients between each GCIPL sector and the corresponding central MS according to FDT 24-2 and 10-2 were all statistically significant, and the correlations were significantly stronger for FDT 10-2 than 24-2 in the inferior and inferonasal sectors. In conclusion, preperimetric glaucoma patients with structural loss in the macula as indicated by GCIPL thinning also exhibited functional loss as revealed by FDT 10-2, and the functional loss was less evident with conventional SAP.Entities:
Mesh:
Year: 2017 PMID: 29116211 PMCID: PMC5676740 DOI: 10.1038/s41598-017-15329-1
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Baseline characteristics.
| Variable | Mean ± standard deviation |
|---|---|
| Age (years) | 71.41 ± 8.95 |
| Sex (male/female) | 26/36 |
| Intraocular pressure (mmHg) | 13.64 ± 2.92 |
| Refraction (diopters) | −2.34 ± 2.82 |
| Axial length (mm) | 23.92 ± 1.31 |
| Central corneal thickness (μm) | 521.54 ± 35.45 |
| Ganglion cell/inner plexiform layer thickness (μm) | |
| Average | 74.24 ± 6.46 |
| Superonasal sector | 78.77 ± 7.77 |
| Superior sector | 75.59 ± 8.88 |
| Superotemporal sector | 76.70 ± 6.43 |
| Inferonasal sector | 74.59 ± 9.03 |
| Inferior sector | 69.16 ± 10.57 |
| Inferotemporal sector | 70.48 ± 10.19 |
| FDT 10-2 | |
| Test duration (min) | 4.16 ± 0.14 |
| MD | −3.19 ± 3.28 |
| PSD | 3.80 ± 1.95 |
| Centre MS (dB) | 27.69 ± 3.61 |
| FDT 24-2 | |
| Test duration (min) | 5.02 ± 0.26 |
| MD | −6.43 ± 4.29 |
| PSD | 4.12 ± 1.30 |
| Centre MS (dB) | 25.61 ± 4.58 |
| SAP 24-2 | |
| Test duration (min) | 4.56 ± 0.36 |
| MD | −1.70 ± 1.71 |
| PSD | 2.15 ± 1.25 |
| VFI | 97.63 ± 2.36 |
| Centre MS (dB) | 30.77 ± 2.07 |
FDT = frequency doubling technology, MD = mean deviation, PSD = pattern standard deviation, MS = mean sensitivity, VFI = visual field index.
Pearson correlations between the ganglion cell/inner plexiform layer thicknesses and the corresponding central visual field sensitivities (in decibels).
| SAP 24-2 (dB) | FDT 24-2 (dB) | FDT 10-2 (dB) | P value* | ||||
|---|---|---|---|---|---|---|---|
| r | P | r | P | r | P | ||
| GCA average | 0.346 | 0.007 | 0.443 | <0.001 | 0.544 | <0.001 | 0.080 |
| Superotemporal sector | 0.192 | 0.183 | 0.212 | 0.004 | 0.297 | 0.021 | 0.152 |
| Superior sector | 0.156 | 0.246 | 0.286 | 0.017 | 0.431 | 0.001 | 0.071 |
| Superonasal sector | 0.119 | 0.365 | 0.368 | 0.010 | 0.455 | <0.001 | 0.070 |
| Inferotemporal sector | 0.435 | 0.001 | 0.602 | <0.001 | 0.607 | <0.001 | 0.475 |
| Inferior sector | 0.392 | 0.002 | 0.407 | 0.004 | 0.611 | <0.001 | 0.011 |
| Inferonasal sector | 0.251 | 0.053 | 0.347 | 0.016 | 0.567 | <0.001 | 0.005 |
*P value comparing the difference in the correlation coefficients between FDT 24-2 and FDT 10-2. SAP = standard automated perimetry, FDT = frequency doubling technology, GCA = ganglion cell analysis.
Pearson correlations between the ganglion cell/inner plexiform layer thicknesses and the central visual field sensitivities (unlogged).
| SAP 24-2 (1/L) | FDT 24-2 (1/K) | FDT 10-2 (1/K) | P value* | ||||
|---|---|---|---|---|---|---|---|
| r | P | r | P | r | P | ||
| GCA average | 0.370 | 0.004 | 0.492 | <0.001 | 0.563 | <0.001 | 0.190 |
| Superotemporal sector | 0.150 | 0.107 | 0.215 | 0.037 | 0.246 | 0.045 | 0.352 |
| Superior sector | 0.163 | 0.226 | 0.323 | 0.019 | 0.435 | 0.001 | 0.111 |
| Superonasal sector | 0.116 | 0.377 | 0.393 | 0.006 | 0.415 | 0.001 | 0.384 |
| Inferotemporal sector | 0.364 | 0.005 | 0.525 | 0.001 | 0.547 | <0.001 | 0.389 |
| Inferior sector | 0.397 | 0.002 | 0.484 | 0.001 | 0.629 | <0.001 | 0.028 |
| Inferonasal sector | 0.386 | 0.002 | 0.365 | 0.011 | 0.532 | <0.001 | 0.029 |
*P value comparing the difference in the correlation coefficients between FDT 24-2 and FDT 10-2. SAP = standard automated perimetry, FDT = frequency doubling technology, GCA = ganglion cell analysis.
Figure 1Structure-function relationships of the average ganglion cell/inner plexiform layer thicknesses and standard automated perimetry 24-2, matrix frequency doubling technology 24-2, and matrix frequency doubling technology 10-2 (logged: A,B and C, respectively; unlogged: D,E and F, respectively).
Figure 2A representative case. A patient with preperimetric glaucoma with thinning of the inferior and inferotemporal sectors in the macular area (F) detected by matrix frequency doubling technology 10-2 (I) and 24-2 (H) but not by standard automated perimetry 24-2 (G).
Figure 3Ganglion cell/inner plexiform layer sectors (A) and the corresponding visual field areas in standard automated perimetry 24-2 (B), matrix frequency doubling technology 24-2 (C), and matrix frequency doubling technology 10-2 (D).